Deepak Pahwa, Director | ET | January 2024
“With less than a fortnight left for the Budget, the pharma industry is hopeful of receiving some major boost from the government. Where India ranks 3rd globally in terms of pharmaceutical production by volume, we are expecting incentives and policies that will strengthen the export prospects of the country. Therefore, in order to reinforce the pharmaceutical supremacy of the country across the globe, in the upcoming budget the government should allot over 2.5% of the pharmaceutical investment towards boosting the manufacturing capacity of the pharma products while ensuring that the products are of the highest quality. The budget should be strategically allotted to promote innovation and tailoring manufacturing practices to meet the rising demand projected in the market while being at par with international standards. On similar lines, to further accelerate the growth of the pharma industry, the upcoming budget should incessantly focus on bolstering the R&D capability to strengthen the manufacturing landscape with the integration of cutting-edge technologies and highly efficient equipment.” Said Mr. Deepak Pahwa, Director, Delair
